Matches in Wikidata for { <http://www.wikidata.org/entity/Q90939827> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q90939827 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90939827 description "scientific article published on 22 October 2019" @default.
- Q90939827 description "wetenschappelijk artikel" @default.
- Q90939827 description "наукова стаття, опублікована 22 жовтня 2019" @default.
- Q90939827 name "Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder" @default.
- Q90939827 name "Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder" @default.
- Q90939827 type Item @default.
- Q90939827 label "Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder" @default.
- Q90939827 label "Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder" @default.
- Q90939827 prefLabel "Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder" @default.
- Q90939827 prefLabel "Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder" @default.
- Q90939827 P1433 Q90939827-62DD95CC-9DB4-4F5B-B54E-9325F6E8A3C7 @default.
- Q90939827 P1476 Q90939827-54D58D83-75E5-49A9-8192-D689003F7EB9 @default.
- Q90939827 P2093 Q90939827-1E7A9236-C4B2-4A4E-987B-38575060D6E7 @default.
- Q90939827 P2093 Q90939827-542E8D7D-5233-4995-9328-F941F6201EFF @default.
- Q90939827 P2093 Q90939827-601C01AC-E25D-4EBA-B36B-1CDD299744DB @default.
- Q90939827 P2093 Q90939827-A70325E7-A652-4F08-8D2D-9DBE7C809DD5 @default.
- Q90939827 P2093 Q90939827-DAE54903-268E-4573-B93F-8A343F6E73AB @default.
- Q90939827 P2860 Q90939827-C606FCF7-5441-4F6D-A1F8-78AAA8EF0D68 @default.
- Q90939827 P31 Q90939827-0E8699EC-7718-4986-BE70-1F76472D3C6A @default.
- Q90939827 P356 Q90939827-E65510C4-FFAE-483E-B63E-335B6B302035 @default.
- Q90939827 P577 Q90939827-BBFE3610-6642-493C-A130-2EE8499166F5 @default.
- Q90939827 P698 Q90939827-899FD135-0844-4883-9BC5-C45ACBD286F9 @default.
- Q90939827 P921 Q90939827-A833B4EE-C758-4460-A984-0A6FFD4A087E @default.
- Q90939827 P921 Q90939827-EE0051F4-655B-4517-B2C8-8C413D69C368 @default.
- Q90939827 P356 ADM.0000000000000584 @default.
- Q90939827 P698 31651562 @default.
- Q90939827 P1433 Q15752435 @default.
- Q90939827 P1476 "Comparing Reasons for Starting and Stopping Methadone, Buprenorphine, and Naltrexone Treatment Among a Sample of White Individuals With Opioid Use Disorder" @default.
- Q90939827 P2093 "Barbara Andraka-Christou" @default.
- Q90939827 P2093 "Jessica Alamo" @default.
- Q90939827 P2093 "Mayur Nadig" @default.
- Q90939827 P2093 "Olivia Randall-Kosich" @default.
- Q90939827 P2093 "Rachel Totaram" @default.
- Q90939827 P2860 Q29618084 @default.
- Q90939827 P31 Q13442814 @default.
- Q90939827 P356 "10.1097/ADM.0000000000000584" @default.
- Q90939827 P577 "2019-10-22T00:00:00Z" @default.
- Q90939827 P698 "31651562" @default.
- Q90939827 P921 Q1639178 @default.
- Q90939827 P921 Q7632070 @default.